Cabaletta Bio Inc. (CABA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cabaletta Bio Inc.

    NASDAQ: CABA · Real-Time Price · USD
    2.36
    0.05 (2.16%)
    At close: Sep 26, 2025, 3:59 PM
    2.36
    -0.02%
    After-hours: Sep 26, 2025, 07:13 PM EDT

    Cabaletta Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 4.81M 1.43M 3.68M 733K
    Gross Profit
    		 -4.81M -1.43M -3.68M -733K
    Operating Income
    		 -125.14M -74.66M -54.14M -46.31M
    Interest Income
    		 10.03M 6.99M 1.16M 24K
    Pretax Income
    		 -115.86M -67.67M -52.98M -46.29M
    Net Income
    		 -115.86M -67.67M -52.98M -46.29M
    Selling & General & Admin
    		 27.94M 19.24M 14.84M 13.82M
    Research & Development
    		 97.2M 55.42M 39.3M 32.49M
    Other Expenses
    		 n/a -1.43M n/a n/a
    Operating Expenses
    		 125.14M 73.23M 54.14M 46.31M
    Interest Expense
    		 748K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 125.14M 74.66M 54.14M 46.31M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 49.52M 40.95M 29.34M 25.74M
    Shares Outstanding (Diluted)
    		 49.47M 40.95M 29.34M 25.74M
    EPS (Basic)
    		 -2.34 -1.65 -1.81 -1.8
    EPS (Diluted)
    		 -2.34 -1.65 -1.81 -1.8
    EBITDA
    		 -125.14M -73.23M -52.96M -45.58M
    EBIT
    		 -116.61M -67.67M -52.98M -46.31M
    Depreciation & Amortization
    		 -8.53M 1.43M 1.18M 733K

    Add to Watchlist